Effect of cilostazol, a cAMP phosphodiesterase inhibitor, on nitric oxide production by vascular smooth muscle cells

European Journal of Pharmacology

Volumn 314, Issue 1-2, 1996, Pages 197-202

  Ikeda, Uichi ^a   Ikeda, Michiyo ^a,b   Kano, Shogo ^a   Kanbe, Toshiko ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UTSUNOMIYA UNIVERSITY   (Japan)

Author keywords

interleukin 1; nitric oxide (NO) synthase; nitrite

Indexed keywords

BUCLADESINE; CILOSTAZOL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DACTINOMYCIN; DEXAMETHASONE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PHOSPHODIESTERASE INHIBITOR; RECOMBINANT INTERLEUKIN 1BETA; RP 8 BROMOADENOSINE 3',5' CYCLIC MONOPHOSPHOROTHIOATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELLS, CULTURED; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLES;

EID: 0030600499     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00551-1     Document Type: Article

References (32)

1. Cooke, J.P. and P.S. Tsao, 1994, Is NO an endogenous antiatherogenic molecule?, Arterioscler. Thromb. 14, 653.
2. De Caterina, R., P. Libby, H.B. Peng, V.L. Thannickal, T.B. Rajavashisth, M.A.A. Gimbrone, W.S. Shin and J.K. Liao, 1995, Nitric oxide decreases cytokine-induced endothelial activation, J. Clin. Invest. 96, 60.
3. Dinerman, J.L., C.J. Lowenstein and S.H. Snyder, 1993, Molecular mechanisms of nitric oxide regulation, Circ. Res, 73, 217.
4. Garg, U. and A. Hassid, 1989, Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells, J. Clin. Invest. 83, 1774.
5. 15N]nitrate in biological fluids, Anal. Biochem. 126, 131.
6. Groves, P.H., W.J. Penny, H.A. Cheadle and M.J. Lewis, 1992, Exogenous nitric oxide inhibits in vivo platelet adhesion following balloon angioplasty, Cardiovasc. Res. 26, 615.
7. Hansson, G.K., Y. Geng, J. Holm, P. Hårdhammar, Å. Wennmalm and E. Jennische, 1994, Arterial smooth muscle cells express nitric oxide synthase in response to endothelia] injury, J. Exp. Med. 180, 733.
8. Hirokawa, K., K. O'Shaughnessy, K. Moore, P. Ramrakha and M.R. Wilkins, 1994, Induction of nitric oxide synthase in cultured vascular smooth muscle cells: the role of cyclic AMP, Br. J. Pharmacol. 112, 396.
9. Ikeda, U., M. Ikeda, T. Oohara, A. Oguchi, T. Kamitani, Y. Tsuruya and S. Kano, 1991, Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner, Am. J. Physiol. 260, H1713.
10. Ikeda, U. and K. Shimada, 1994, Nitric oxide release from rat aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitor, Eur. J. Pharmacol. 269, 319.
11. Ikeda, U., Y. Maeda, T. Kawahara, M. Yokoyama and K. Shimada, 1995, Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes, Circulation 92, 2683.
12. Ikeda, U., K. Yamamoto, M. Ichida, F. Ohkawa, M. Murata, O. Iimura, E. Kusano, Y. Asano and K. Shimada, 1996, Cyclic AMP augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes, J. Mol. Cell. Cardioi. 28, 789.
13. Jessup, W., D. Mohr, S. Gieseg, R. Dean and R. Stocker, 1992, The participation of nitric oxide in cell-free and its restriction of macrophage-mediated oxidation of low-density lipoprotein, Biochem. Biophys. Acta 1180, 73.
14. Joly, G.A., V.B. Schini and P.M. Vanhoutte, 1992, Balloon injury and interleukin-1 β induce nitric oxide synthase activity in rat carotid cateries, Circ. Res. 71, 331.
15. Karaki, H., K. Sato, H. Ozaki and K. Murakami, 1988, Effects of sodium nitroprusside on cytosolic calcium level in vascular smooth muscle cell, Eur. J. Pharmacol. 156, 259.
16. Koide, M., Y. Kawahara, I. Nakayama, T. Tsuda and M. Yokoyama, 1993, Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells, J. Biol. Chem. 268, 24959.
17. Lowenstein, C.J., C.S. Glatt, D.S. Bredt and S.H. Snyder, 1992, Cloned and expressed macrophage nitric oxide synthase contrasts with the brain, Proc. Natl. Acad. Sci. USA 89, 6711.
18. Marcinkiewicz, J. and B.M. Chain, 1993, Differential regulation of cytokine production by nitric oxide, Immunology 80, 146.
19. Moncada, S., R.M.J. Palmer and E.A. Higgs, 1991, Nitric oxide: physiology, pathophysiology and pharmacology, Pharmacol. Rev. 43, 109.
20. Montminy, M. and L. Bilezikjian, 1987, Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene, Nature 328, 175.
21. Mühl, H., D. Kunz and J. Pfeilschifter, 1994, Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP, Br. J. Pharmacol. 112, 1.
22. Nathan, C. and Q. Xie, 1994, Regulation of biosynthesis of nitric oxide, J. Biol. Chem. 269, 13725.
23. Niu, X., C.W. Smith and P. Kubes, 1994, Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils, Circ. Res. 74, 1133.
24. Oddis, C.V., R.L. Simmons, B.G. Hattler and M.S. Finkel, 1995, cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes, Am. J. Physiol. 269, H2044.
25. Radomski, M.W., R.M.J. Palmer and S. Moncada, 1987, Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets, Br. J. Pharmacol. 92, 181.
26. Roesler, W.J., G.R. Vandenbark and R.W. Hanson, 1988, Cyclic AMP and the induction of eukaryotic gene transcription, J. Biol. Chem. 263, 9063.
27. Saitoh, S., T. Saitoh, A. Otake, T. Owada, M. Mitsugi, H. Hashimoto and Y. Maruyama, 1993, Cilostazol, a novel cyclic AMP phosphodiesterase inhibitor, prevents reocculsion after coronary arterial thrombolysis with recombinant tissue-type plasminogen acitvator, Arterioscler. Thromb. 13, 563.
28. Takahashi, S., K. Oida, R. Fujiwara, H. Maeda, S. Hayashi, H. Takai, T. Tamai, T. Nakai and S. Miyabo, 1992, Effect of cilostazol, a cyclic AMP posphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture, J. Cardiovasc. Pharmacol. 20, 900.
29. Umekawa, H., T. Tanaka, Y. Kimura and H. Hidaka, 1984, Purificationof cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor Sepharose chromatography, Biochem. Pharmacol. 33, 3339.
30. Xie, Q., R. Whisnant and C. Nathan, 1993, Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility of interferon γ and bacterial lipopolysaccharide, J. Exp. Med. 17, 1779.
31. Yamamoto, K., G. Gonzalez, III., W. Biggs and M. Montminy, 1988, Phospho-rylation-induced binding and transcriptional efficacy of nuclear factor CREB, Nature 334, 494.
32. Yasuda, K., A. Sakuma and T. Tanabe, 1985, Hemodynamic effect of Cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans, Arzneim.-Forsch./Drug Res. 35, 1198.